SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024240
Filing Date
2020-05-11
Accepted
2020-05-11 16:26:36
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20200331.htm 10-Q 1177399
2 EX-10.1 logc-ex101_12.htm EX-10.1 78496
3 EX-31.1 logc-ex311_7.htm EX-31.1 18542
4 EX-31.2 logc-ex312_6.htm EX-31.2 18330
5 EX-32.1 logc-ex321_9.htm EX-32.1 7607
  Complete submission text file 0001564590-20-024240.txt   4429001

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT logc-20200331.xml EX-101.INS 817334
7 XBRL TAXONOMY EXTENSION SCHEMA logc-20200331.xsd EX-101.SCH 36941
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20200331_cal.xml EX-101.CAL 45487
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20200331_def.xml EX-101.DEF 99572
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20200331_lab.xml EX-101.LAB 309698
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20200331_pre.xml EX-101.PRE 229037
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 20865216
SIC: 2836 Biological Products, (No Diagnostic Substances)